Article ID Journal Published Year Pages File Type
9380644 Journal of Affective Disorders 2005 6 Pages PDF
Abstract
The results of this trial provide preliminary evidence that aripiprazole may be an effective adjunctive treatment in individuals on SSRIs with residual symptoms of anxiety or depression. More rigorous double-blind studies are warranted to confirm and elucidate the potential role of aripiprazole in these conditions.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Psychiatry and Mental Health
Preview
Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors
Authors
, , ,